← Leaderboards
Richard Goldstein
Boston Medical Center
$2,188,221
Attributed
$2,188,221
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $359.9K · FY2005–11$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$2,188,221 · 5
By mechanism
R01$1,461,821 · 1
R21$623,638 · 2
R55$100,000 · 1
M01$2,762 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Otitis Media”
- Lauren O Bakaletz · Research Inst Nationwide Children'S Hosp$21,163,452
- Jian-Dong Li · House Ear Institute$17,130,477
- Garth D. Ehrlich · Allegheny-Singer Research Institute$14,763,154
- Allen F Ryan · Va San Diego Healthcare System$10,240,920
- Lawrence D Shriberg · University Of Wisconsin Madison$9,879,187
- Stephen A Boppart · Medical College Of Wisconsin$9,557,932
Research focus
Otitis MediaDisease /Disorder ModelChinchillaHaemophilus InfluenzaeBacterial GeneticsMass SpectrometryVaccine DevelopmentBacteria Infection MechanismLipopolysaccharidesVirulenceEnzyme Linked Immunosorbent AssayFundingAntibodiesEnv Gene ProductsBacterial Cytopathogenic EffectComplement ActivationChildCategoriesAntimicrobial ResistanceAnimalsCodeChildhoodAntimicrobialBioinformatics
Grant awards (10)
Recombination-quiescent genes & phylogenic validation of encoded vaccine targets$209,138
R21 · FY2011 · AI · contact PI
Recombination-quiescent genes & phylogenic validation of encoded vaccine targets$253,500
R21 · FY2010 · AI · contact PI
THE KINETICS OF HIGH MOBILITY GROUP BOX-1 (HMGB1)$2,762
M01 · FY2008 · RR · contact PI
NTHi LPS: virulence factor and vaccine candidate$351,425
R01 · FY2006 · DC · contact PI
NTHi LPS: virulence factor and vaccine candidate$359,882
R01 · FY2005 · DC
NTHi LPS: virulence factor and vaccine candidate$359,882
R01 · FY2004 · DC
NTHi LPS: virulence factor and vaccine candidate$390,632
R01 · FY2003 · DC
Role of sialylated LPS in H. influenzae otitis media$80,500
R21 · FY2003 · DC
Role of sialylated LPS in H. influenzae otitis media$80,500
R21 · FY2002 · DC
MICROBIAL POPULATION STRATEGY FOR VACCINE DEVELOPMENT$100,000
R55 · FY2001 · DC